Altogether, members of the specialty collected nearly 5,800 of these payments in 2024, from sources such as pharmaceutical companies and imaging device manufacturers.
Medmo and Covera Health, both based in New York, officially announced their merger on April 21, with the latter’s lead investor, Insight Partners, funding the deal.
By and large, U.S. hospitals and health systems do not have an AI adoption problem. But many—if not most—have an execution problem: They struggle to turn a set of installed AI tools into a measurable operational value.
Family physicians and other primary care providers don’t mind being held to account for care quality by healthcare administrators. The rub is that multiple other stakeholders often demand similar levels of answerability, pulling the doctors in different directions at once.
Developed by a board-certified diagnostic and interventional radiologist, the platform was trained using subspecialty data that general AI applications typically lack.
Christoph Wald, MD, vice chair of the American College of Radiology Board of Chancellors, explains the resources available to practices looking to bolster cybersecurity.
Although the company is already bringing in revenue from medical radioisotopes, the new funding will help further these initiatives and drive additional research and development.
The recall is officially an early alert, as the syringes are part of surgical convenience kits—the rest of which are safe to use. The defective syringes risk causing fatal injuries to patients and must be discarded.
The maker of popular GLP-1 agonists Wegovy and Ozempic said technology from OpenAI, the company behind ChatGPT, will allow it to sift through and make sense of massive datasets to identify potential new uses for its diabetes and obesity treatments.
The Spectral CT Verida system is powered by artificial intelligence, offering users AI-enabled image reconstructions, improved noise reduction and enhanced image quality.
Altogether, members of the specialty collected nearly 5,800 of these payments in 2024, from sources such as pharmaceutical companies and imaging device manufacturers.
